SCHEMBL2198256

SCHEMBL2198256

COC(=O)c1ccc(OC)c(C(=O)c2ccc([N+](=O)[O-])cc2Cl)c1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.63
HTT P42858 3/20 0.63
GAA P10253 1/20 0.63
NPSR1 Q6W5P4 1/20 0.63
MAPT P10636 6/20 0.54
POLB P06746 3/20 0.54
TDP1 Q9NUW8 2/20 0.54
PYGL P06737 1/20 0.50
LMNA P02545 4/20 0.49
NPC1 O15118 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
KDM4E B2RXH2 1/20 0.49
KMT2A Q03164 5/20 0.48
MEN1 O00255 3/20 0.47
RORC P51449 1/20 0.47
MCL1 Q07820 1/20 0.46
THRB P10828 1/20 0.45
PKM P14618 1/20 0.45
ALDH1A1 P00352 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2197879 0.89 MAPK1 (0.64) MAPK1HTTGAANPSR1MAPT
SCHEMBL2195784 0.87 MAPK1 (0.61) MAPK1HTTGAANPSR1MAPT
SCHEMBL2195775 0.87 MAPK1 (0.64) MAPK1HTTGAANPSR1MAPT
SCHEMBL2855075 0.83 MAPK1 (0.59) MAPK1HTTGAANPSR1MAPT
SCHEMBL7974512 0.81 MAPK1 (0.57) MAPK1HTTGAANPSR1MAPT
SCHEMBL2198682 0.81 KMT2A (0.46) HTTGAANPSR1MAPTPOLB
SCHEMBL2196600 0.81 MAPT (0.48) HTTGAANPSR1MAPTPOLB
SCHEMBL222270 0.79 TDP1 (0.67) MAPK1HTTGAANPSR1MAPT
SCHEMBL9384153 0.79 LMNA (0.70) MAPK1HTTGAANPSR1MAPT
SCHEMBL6846139 0.78 MAPK1 (1.00) MAPK1HTTGAANPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1658263-B9 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2011-11-09 EP disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
EP-1658263-B1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2010-06-02 EP disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed
EP-1658263-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS Leo Pharma A/S (DK) 2006-05-24 EP disclosed
WO-2005009940-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA A/S (DK) 2005-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK1 523/4885HTT 4225/4885GAA 2276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.